Analysis of Measles and Rubella Immunoglobulin G Titers in COVID-19 Patients
We believe that the pre-existing Anti-Rubella IgG antibodies in the patient may increase in parallel with the patient's viral load by recognizing the common macrodomain of SARS-CoV-2 and Rubella viruses. The common macrodomain of SARS-CoV-2 and Rubella viruses is also present in the attenuated rubella virus used in the MMR vaccine4. In this case, we predict that previously administered MMR vaccine may be protective for COVID-19 patients. disease compared to those with mild disease.
Authors
- Hacer İşler (ORCID: https://orcid.org/0000-0002-0722-8425)
- Melek Bilgin (ORCID: https://orcid.org/0000-0003-0025-8717)
- Ahmet Şen (ORCID: https://orcid.org/0000-0001-8981-6871)
- Eşe Başbulut (ORCID: https://orcid.org/0000-0001-8235-9524)
- Süleyman Sırrı KILIÇ (ORCID: https://orcid.org/0000-0002-0238-8008)
- Mahcube Çubukçu (ORCID: https://orcid.org/0000-0003-4799-6848)
Institutions
- Samsun University (TR)
- Türk Anesteziyoloji ve Reanimasyon Derneği (TR)
Publication Details
- Journal
- Risk Management and Healthcare Policy
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/rmhp.s472872
- Citations
- 1
- Primary Topic
- Immune responses and vaccinations
- Type
- article
- Field-Weighted Citation Impact
- 0.24